PENDEKATAN DIAGNOSIS DAN TATA LAKSANA PORFIRIA KUTAN PADA ANAK

Authors

  • Sesilia Sutanto dr.
  • Githa Rahmayunita Indonesia
  • Roro Inge Ade Krisanti Indonesia
  • Triana Agustin Indonesia
  • Klara Yuliarti Indonesia
  • Agassi Suseno Sutarjo Indonesia

DOI:

https://doi.org/10.33820/mdvi.v53i2.568

Keywords:

porfiria, porfiria kutan anak, heme, fotosensitivitas

Abstract

 

 Porfiria adalah kelainan metabolisme bawaan (inborn error of metabolism) yang disebabkan oleh defek enzim pada jalur biosintesis heme, sehingga mengakibatkan akumulasi porfirin dan prekursornya. Porfiria kutan pada anak, seperti protoporfiria eritropoietik, porfiria eritropoietik kongenital, dan porfiria hepatoeritropoietik umumnya ditandai dengan fotosensitivitas serta lesi kulit khas pada area terpajan sinar matahari. Manifestasi klinis dapat berupa nyeri, eritema, vesikel atau bula, hingga skar. Selain kelainan kulit, komplikasi sistemik berupa gangguan hepatobilier dan hematologis juga dapat terjadi yang memperburuk prognosis pasien. Diagnosis porfiria pada anak sering terlambat akibat kurangnya kesadaran dan pengetahuan tentang penyakit ini. Pendekatan diagnosis dilakukan dengan pemeriksaan klinis, pemeriksaan kadar porfirin dalam darah, urin, dan feses, serta konfirmasi melalui pemeriksaan genetik. Tata laksana umumnya bersifat suportif dan preventif, terutama dengan menghindari pajanan sinar matahari dan menggunakan fotoproteksi. Oleh karena itu, pemahaman yang baik mengenai penyakit ini penting untuk diagnosis dini dan tatalaksana yang tepat guna mencegah komplikasi serta meningkatkan kualitas hidup pasien.

Downloads

Download data is not yet available.

References

Gou EW, Anderson KE. The Porphyrias. Dalam: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, penyunting. Fitzpatrick’s Dermatology. Edisi ke-9. New York: McGraw-Hill Education; 2019. hlm. 2234–57.

Linenberger M, Fertrin KY. Updates on the diagnosis and management of the most common hereditary porphyrias: AIP and EPP. Hematology Am Soc Hematol Educ Program. 2020;1:400–10.

Chakraborty A, Muranjan M, Karande S, Kharkar V. Porphyrias: uncommon disorders masquerading as common childhood diseases. J Postgrad Med. 2023;69(3):164–71.

Frank J. The Porphyrias. Dalam: Hoeger P, Kinsler V, Yan A, penyunting. Harper’s Textbook of Pediatric Dermatology. Edisi ke-4. Hoboken: Wiley-Blackwell; 2020. hlm. 957–68.

Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164–77.

Ahmed I. Childhood porphyrias. Mayo Clin Proc. 2002;77:825-36.

Michaels BD, Del Rosso JQ, Mobini N, Michaels JR. Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol. 2010;3(7):44.

Dickey AK, Naik H, Keel SB, Levy C, Beaven SW, Elmariah SB, et al. Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria. J Am Acad Dermatol. 2023;89(6):1227–37.

Dickey AK, Leaf RK, Balwani M. Update on the Porphyrias. Annu Rev Med. 2024;75(1):321–35.

Lecluse AL, Kuck-Koot VC, Van Weelden H, Sigurdsson V, Russel IM, Frank J, et al. Erythropoietic protoporphyria without skin symptoms – you do not always see what they feel. Eur J Pediatr. 2008;167:703–6.

Minder AE, Kluijver LG, Barman-Aksözen J, Minder EI, Langendonk JG. Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management. Liver Int. 2025;45(1):1-16.

Lecha M, Puy H, Deybach JC. Erythropoietic protoporphyria. Orphanet J Rare Dis. 2009;4:1–10.

Kahila A, Zamlout A, Mazloum A, Laila O, Badran A. Congenital erythropoietic porphyria (Gunther disease): a case report. Oxf Med Case Rep. 2020;7:227-30.

Howard M, Hall T, Ramsay D. Congenital erythropoietic porphyria (Gunther disease) – Long-term follow-up of a case and review. 2017;23(2):1-7.

Bhavasar R, Santoshkumar G, Prakash BR. Erythrodontia in congenital erythropoietic porphyria. J Oral Maxillofac Pathol. 2011;15(1):69–73.

Erwin A, Balwani M, Desnick RJ. Congenital erythropoietic porphyria. Dalam: Adam MP, Feldman J, Mirzaa GM, et al., penyunting. GeneReviews [Internet]. 2021. [Disitasi 18 Oktober 2024]. Tersedia dari: https://www.ncbi.nlm.nih.gov/ books/ NBK1116/

To-Figueras J, Erwin AL, Aguilera P, Millet O, Desnick RJ. Congenital erythropoietic porphyria. Liver Int. 2024;44(8):1842-55.

Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol. 2006;135(3):281–92.

Mohammed M. Hepatoerythropoietic Porphyria Misdiagnosed as Child Abuse. Dalam: Tohid H, Baratta LG, Maibach H, penyunting. The Misdiagnosis Casebook in Clinical Medicine: a Case-Based Guide. Springer; 2023. hlm. 267–73.

Weiss Y, Chen B, Yasuda M, Nazarenko I, Anderson KE, Desnick RJ. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations. Mol Genet Metab. 2019;128(3):363–6.

Rudnick S, Phillips J, Bonkovsky H. Porphyrias consortium of the rare diseases clinical research network. Familial porphyria cutanea tarda. Dalam: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, et al., penyunting. GeneReviews [Internet]. 2022. [Disitasi 3 Desember 2024]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK1113/

Katugampola RP, Badminton MN, Finlay AY, Whatley S, Woolf J, Mason N, et al. Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases. Br J Dermatol. 2012;167(4):901–13.

Mathews-Roth MM, Rosner B. Long-term treatment of erythropoietic protoporphyria with cysteine. Photodermatol Photoimmunol Photomed. 2002;18(6):307–9.

Balwani M, Bonkovsky HL, Levy C, Anderson KE, Bissell DM, Parker C, et al. Dersimelagon in erythropoietic protoporphyrias. N Engl J Med. 2023;388(15):1376–85.

Halloy F, Iyer PS, Ghidini A, Lysenko V, Barman-Aksözen J, Grubenmann CP, et al. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria. Cell Chem Biol. 2021;28(8):1221–34.

Scott M. Bitopertin for Erythropoietic Protoporphyria: A New Paradigm—and New Hope—for a Rare, Devastating Disease. The Hematologist. 2023;20(6).

Heerfordt IM, Lerche CM, Wulf HC. Cimetidine for erythropoietic protoporphyria. Photodiagnosis Photodyn Ther. 2022;38:102793.

Sassa S. Hematologic aspects of the porphyrias. Int J Hematol. 2000;71(1):1–17.

Neeleman R, Wensink D, Wagenmakers M, Mijnhout G, Friesema E, Langendonk J. Diagnostic and therapeutic strategies for porphyrias. Neth J Med. 2020;78(4):149–60.

Published

2026-06-30

How to Cite

Sutanto, S., Rahmayunita, G., Krisanti, R. I. A., Agustin, T., Yuliarti, K., & Sutarjo, A. S. (2026). PENDEKATAN DIAGNOSIS DAN TATA LAKSANA PORFIRIA KUTAN PADA ANAK. Media Dermato-Venereologica Indonesiana, 53(2), 136–144. https://doi.org/10.33820/mdvi.v53i2.568